Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Shares Issued (2019 - 2025)

Biodesix's Shares Issued history spans 7 years, with the latest figure at $2.3 million for Q4 2025.

  • For Q4 2025, Shares Issued fell 95.83% year-over-year to $2.3 million; the TTM value through Dec 2025 reached $7.3 million, down 86.84%, while the annual FY2025 figure was $7.3 million, 86.84% down from the prior year.
  • Shares Issued reached $2.3 million in Q4 2025 per BDSX's latest filing, down from $5.0 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $59.4 million in Q4 2022 to a low of -$55.6 million in Q3 2024.
  • Average Shares Issued over 5 years is $8.6 million, with a median of $1.1 million recorded in 2021.
  • Peak YoY movement for Shares Issued: soared 197863.33% in 2022, then tumbled 463.44% in 2024.
  • A 5-year view of Shares Issued shows it stood at $30000.0 in 2021, then skyrocketed by 197863.33% to $59.4 million in 2022, then crashed by 79.46% to $12.2 million in 2023, then soared by 355.79% to $55.6 million in 2024, then tumbled by 95.83% to $2.3 million in 2025.
  • Per Business Quant, the three most recent readings for BDSX's Shares Issued are $2.3 million (Q4 2025), $5.0 million (Q3 2025), and $55.6 million (Q4 2024).